AbbVie (Q12444): Difference between revisions
Jump to navigation
Jump to search
Created claim: part of (P7): S&P 100 (Q12445) |
Added link to [en]: AbbVie |
||||||||||||||
(10 intermediate revisions by the same user not shown) | |||||||||||||||
Property / logo image | |||||||||||||||
Property / logo image: AbbVie logo.svg / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / industry | |||||||||||||||
Property / industry: pharmaceutical industry / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / inception | |||||||||||||||
1 January 2013
| |||||||||||||||
Property / inception: 1 January 2013 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / country | |||||||||||||||
Property / country: United States of America / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / member of | |||||||||||||||
Property / member of: European Federation of Pharmaceutical Industries and Associations / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / legal form | |||||||||||||||
Property / legal form: public company / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / stock exchange | |||||||||||||||
Property / stock exchange: New York Stock Exchange / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / stock exchange: New York Stock Exchange / qualifier | |||||||||||||||
ticker symbol: ABBV | |||||||||||||||
Property / stock exchange: New York Stock Exchange / qualifier | |||||||||||||||
start time: 2 January 2013
| |||||||||||||||
Property / product or material produced | |||||||||||||||
Property / product or material produced: medication / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / official website | |||||||||||||||
Property / official website: http://www.abbvie.com / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / official website: http://www.abbvie.com / qualifier | |||||||||||||||
Property / Commons category | |||||||||||||||
AbbVie Inc. | |||||||||||||||
Property / Commons category: AbbVie Inc. / rank | |||||||||||||||
Normal rank | |||||||||||||||
links / en / name | links / en / name | ||||||||||||||
Latest revision as of 13:28, 24 June 2023
pharmaceutical company
- AbbVie Inc.
Language | Label | Description | Also known as |
---|---|---|---|
English | AbbVie |
pharmaceutical company |
|
Statements
1 January 2013
0 references
AbbVie Inc.
0 references